期刊文献+

不同减重术式对GK大鼠骨骼肌SIRT3酶表达的影响

Effect of different weight losing method on SIRT3 enzyme in skeletal muscle of GK rats
下载PDF
导出
摘要 目的:探讨不同减重术式对GK大鼠骨骼肌SIRT3酶表达的影响。方法:24只Goto-Kakizaki(GK)大鼠随机分为Roux-en-Y胃转流手术组(Roux-en-Y Bypass group RY组,n=8)、袖状胃切除手术组(Sleeve gastrectomy group SG组,n=8)、胃绑带手术组(Gastric banding group GB组,n=8),3组分别行相应术式,分别测定术前、术后48h和1、2及4周空腹血糖水平,术后4周处死大鼠取大腿部骨骼肌,用western blot法半定量测定其SIRT3酶值。结果:术前3组大鼠空腹血糖水平相仿,术后3组血糖均有不同程度下降,以RY组和SG组下降明显,RY组和SG组下降差异无统计学意义(P>0.05),与GB组相比差异有统计学意义(P<0.05),同样3组术后骨骼肌SIRT3酶表达均有增加,以RY组和SG组增加明显,RY组和SG组增加差异无统计学意义(P>0.05),与GB组相比差异有统计学意义(P<0.05)。结论:不同减重术式均可增加GK大鼠骨骼肌SIRT3酶表达,尤以Roux-en-Y胃转流手术和袖状胃切除手术对其影响明显。 Objective. To explore effect of different weight losing method on SIRT3 enzyme in skeletal muscle of Goto-Kakizaki (GK) rats. Methods. A total of 24 GK rats were randomly divided into Roux-en-Y (RY) group (n=8), sleeve gastrectomy (SG) group (n=8) and gastric banding (GB) group (n;8). Fasting blood-glucose level before surgery, 48 h, 1 week, 2 weeks, and 4 weeks after surgery were measured. Rats were killed 4 weeks after surgery, and skeletal muscle from huckle were taken. SIRT3 was detected by western blot. Results. There was no difference in fasting blood-glucose level among three groups before surgery. And the levels were decreased after surgery in three groups. The decrease was more significant in RY and SG group, but the difference was not significant between these two groups (P〈0.05). SIRT3 was increased after surgery in three groups. The increase was more significant in RY and SG group, but the difference was not significant between these two groups(P〈0.05). Conclusions. Three weight losing methods all can increase SIRT3 expression, and the effect of Roux-en-Y gastric bypass and sleeve gastrectomy are more significant.
出处 《海南医学院学报》 CAS 2013年第5期586-588,592,共4页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210621)~~
关键词 减重手术 Goto-Kakizaki大鼠 SIRT3 Weight losing surgery Goto-Kakizaki rat SIRT3
  • 相关文献

参考文献11

  • 1Camastra S. Bariatric surgery as a treatment of type 2 diabetes[J]. Recenti Prog Med, 2011,102(2): 82-87.
  • 2Huttl TP, Karl-Walter J. Bariatric surgery: fighting o- besity and diabetes with a scalpel[J]. MMW Fortschr Med, 2010,152(22): 28.
  • 3Tejirian T, Jensen C, Dutson E. Bariatric surgery and type 2 diabetes mellitus: surgically induced remission [J]. J Diabetes Sei Technol, 2008, 2(4) : 685-691.
  • 4Kashyap SR. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients[J]. Cleve Clin J Med, 2010,77(7): 468-476.
  • 5Schernthaner G, Morton JM. Bariatric surgery in pa- tients with morbid obesity and type 2 diabetes[J]. Dia- betes Care, 2008,31( Suppl 2): S297-302.
  • 6de Aquino LA,Pereira SE, de Souza Silva J ,et al. Bari- atric surgery impact on body composition after Roux- en-Y gastric bypass[J]. Obes Surg, 2012 ,22 (2)..195- 200.
  • 7Marantos G, Daskalakis M, Karkavitsas N, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with re- strictive bariatric surgery[J]. World J Surg, 2011, 35 (9) .. 2022-2030.
  • 8Unick JL, Bond DS, Jakicic JM, et al. Comparison of Two Objective Monitors for Assessing Physical Activity and Sedentary Behaviors in Bariatric Surgery Patients. Obes Surg, 2012,22(3) :347-352.
  • 9Giralt A, Villarroya F. SIRT3, a pivotal actor in mito- chondrial functions: metabolism, cell death and aging [J]. Biochem J, 2012,444(1) : 1-10.
  • 10Jing E, Emanuelli B, Hirschey MD, et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insu- lin signaling via altered mitochondrial oxidation and re- active oxygen species production[J]. Proc Natl Acad Sci U S A, 2011,108(35): 14608-14613.

二级参考文献12

  • 1Payne JH,DeWind LT. Surgical treatment of obesity[J].American Journal of Surgery,1969,(02):141-147.
  • 2Scott H W Jr,Dean R. Considerations in the use of Jejunoileal bypass in patients with morbid obesity[J].Annals of Surgery,1973,(06):323-335.
  • 3Patriti A,Facchiano E,Donini A. Effect of duodenaljejunal exclusion in a non-obese animal model of type 2 diabetes:a new perspective for and old disease[J].Annals of Surgery,2004,(02):388-389.
  • 4Cummings DE,O verduin J,Foster-Schubert KE. Gastric bypass for obesity:M ecganism of weight loss and diabetes resolution[J].J C lin Endocrin M etab,2004,(06):2608-2615.
  • 5Schauer PR,Burguera B,Ikramuddin S. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus[J].Annals of Surgery,2003,(04):467-484.
  • 6Clements RH,Gonzalez QH,Long C I. Hormonal changes after Roux-en-Y gastric bypass for morbid obesity and the control of type-Ⅱ diabetes mellitus[J].Annals of Surgery,2004,(01):1-4.
  • 7Sugerman HJ,Wolfe LG,Sica DA. Diabetes and hypertension in severe obesity and effects of gastric bypass induced weight loss[J].Annals of Surgery,2003,(06):751-756.doi:10.1097/00000658-200306000-00002.
  • 8Flatt PR. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide(GIP):evidence and clinical opportunity for development of new obesity-diabetes drug[J].Diab Vasc Dis Res,2007,(02):151-153.
  • 9Bellizzi D,Rose C,Cavalcante P. Anovel VNTR enhancer within the SIRT3 gene,a human homologue of SIR2,is associated with survival at oldest ages[J].Genomics,2005,(02):258-263.
  • 10Yechoor V K,Patti M E,Ueki K. Distinct pathways of insulin-regulated versus diabetes regulated gene expression:An in vivo analysis in MIRKO mice[J].Proceedings of the National Academy of Sciences(USA),2004,(47):16525-16530.doi:10.1073/pnas.0407574101.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部